IP Verse

Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters

Patent No. EP2234617 (titled "Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters") was filed by Janssen Pharmaceutica on Dec 17, 2008. The application was issued on Nov 6, 2024.

Patent Summary

A long-acting injectable formulation of paliperidone palmitate for treating schizophrenia and other psychiatric disorders. The formulation is administered via intramuscular injection, with a loading dose of 150-200 mg paliperidone palmitate given in the deltoid muscle on the first day, followed by a second loading dose of 100 mg paliperidone palmitate in the deltoid muscle 7-10 days later. Subsequent maintenance doses of 25-150 mg paliperidone palmitate are administered every 4 weeks, either in the deltoid or gluteal muscle. The formulation is an aqueous nanoparticle suspension that provides sustained release of paliperidone over a 4-week period.

Patent Family

Patent Family

Patent Oppositions (20)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EGISDec 31, 2021STOLMAR & PARTNER
ZENTIVA KSDec 31, 2021REDDIE & GROSE
HOFFMANN EITLEDec 30, 2021HOFFMANN EITLE
FARMAPROJECTS SAUDec 29, 2021DE LA CRUZ RIDAO
GILL JENNINGS & EVERYDec 29, 2021GILL JENNINGS & EVERY
LABORATORIOS LESVIDec 28, 2021TER MEER STEINMEISTER & PARTNER
SUN PHARMACEUTICAL INDUSTRIES EUROPEDec 27, 2021BIRD & BIRD
TOLMARDec 27, 2021STEFFAN & KIEHNE PATENTANWALTE PARTG MBB
BIOGARANDec 23, 2021CASALONGA
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBDec 23, 2021ELKINGTON AND FIFE
ACCORD HEALTHCAREDec 22, 2021BRAND MURRAY FULLER
EVER VALINJECTDec 22, 2021GASSNER
HOFFMANN EITLEDec 22, 2021HOFFMANN EITLE
ABBOTTDec 20, 2021REDDIE & GROSE
MAIWALDDec 20, 2021MAIWALD
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIDec 20, 2021SONNENHAUSER
STADA ARZNEIMITTELDec 17, 2021HAMM & WITTKOPP
INSTONEDec 10, 2021APPLEYARD LEES
ADVANZ PHARMA SERVICES UKDec 3, 2021FUCHS PATENTANWALTE PARTNERSCHAFT MBB
TEVA PHARMACEUTICALSMar 31, 2021D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2234617

JANSSEN PHARMACEUTICA
Application Number
EP08863534A
Filing Date
Dec 17, 2008
Status
Patent Maintained As Amended
Oct 3, 2024
Publication Date
Nov 6, 2024
External Links
Slate, Register , Google Patents